Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 47.20%94.31M | ---- | 73.77%64.07M | ---- | -85.38%36.87M | ---- | 47.60%252.12M | ---- | -10.82%170.81M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 14.29%-1.02M | ---- | -81.13%-1.19M | ---- | -59.08%-657K | ---- | 5.92%-413K | ---- | 55.84%-439K |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 56.11%-1M | ---- | -123.36%-2.29M |
| Impairment and provisions: | ---- | -107.94%-1.2M | ---- | 9.55%15.14M | ---- | --13.82M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -107.94%-1.2M | ---- | 9.55%15.14M | ---- | --13.82M | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | 152.87%774K | ---- | -1,609.28%-1.46M | ---- | 108.21%97K | ---- | -1,257.84%-1.18M | ---- | 102.89%102K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---1.3M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 571.95%774K | ---- | -269.07%-164K | ---- | 108.21%97K | ---- | -1,257.84%-1.18M | ---- | 103.95%102K |
| Depreciation and amortization: | ---- | -12.42%62.8M | ---- | -7.45%71.7M | ---- | 2.25%77.47M | ---- | 3.22%75.77M | ---- | 4.95%73.4M |
| -Depreciation | ---- | -12.42%62.8M | ---- | -7.45%71.7M | ---- | 2.25%77.47M | ---- | 3.22%75.77M | ---- | 4.95%73.4M |
| Financial expense | ---- | -13.53%29.74M | ---- | -5.18%34.39M | ---- | -13.45%36.27M | ---- | 56.04%41.9M | ---- | 19.26%26.85M |
| Operating profit before the change of operating capital | ---- | 1.51%185.4M | ---- | 11.46%182.65M | ---- | -55.37%163.87M | ---- | 36.78%367.2M | ---- | -3.59%268.45M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 189.65%45.08M | ---- | 10.60%-50.28M | ---- | -276.03%-56.24M | ---- | 485.09%31.95M | ---- | -112.80%-8.3M |
| Accounts receivable (increase)decrease | ---- | -281.90%-61.37M | ---- | 213.81%33.74M | ---- | -3,386.59%-29.65M | ---- | -75.25%902K | ---- | 160.50%3.65M |
| Accounts payable increase (decrease) | ---- | -153.95%-149.22M | ---- | 387.82%276.62M | ---- | -17.08%56.71M | ---- | 1,430.23%68.39M | ---- | -108.81%-5.14M |
| prepayments (increase)decrease | ---- | 110.93%39.66M | ---- | -2,632.41%-362.84M | ---- | 104.17%14.33M | ---- | -734.99%-343.68M | ---- | -30.06%-41.16M |
| Cash from business operations | 156.82%179.09M | -25.46%59.54M | 8.96%69.74M | -46.39%79.88M | -41.01%64M | 19.45%149.01M | 18.90%108.49M | -42.64%124.76M | -62.52%91.25M | -40.25%217.5M |
| Other taxs | 3.18%-19.7M | 9.81%-40.66M | -34.51%-20.35M | 18.75%-45.09M | 11.43%-15.13M | 10.12%-55.49M | 56.28%-17.08M | -75.95%-61.74M | -55.37%-39.07M | 28.30%-35.09M |
| Net cash from operations | 222.74%159.39M | -45.74%18.88M | 1.06%49.39M | -62.79%34.8M | -46.54%48.87M | 48.42%93.52M | 75.18%91.41M | -65.45%63.01M | -76.10%52.18M | -42.10%182.41M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -57.00%301K | -14.29%1.02M | -6.79%700K | 81.13%1.19M | --751K | 59.08%657K | ---- | -5.92%413K | ---- | -55.84%439K |
| Sale of fixed assets | -21.80%1.98M | 48.94%7.06M | 1,489.31%2.53M | 1,468.87%4.74M | -4.79%159K | -97.01%302K | -71.26%167K | 1,088.60%10.12M | -22.74%581K | -64.36%851K |
| Purchase of fixed assets | 41.23%-4.2M | 68.46%-15.21M | 76.73%-7.15M | -297.26%-48.22M | -2,055.75%-30.74M | 49.00%-12.14M | 81.70%-1.43M | 45.42%-23.8M | 60.91%-7.79M | 46.08%-43.61M |
| Sale of subsidiaries | ---- | ---- | ---- | --520K | --520K | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | 110.20%412K | ---- | 35.17%196K | ---- |
| Net cash from investment operations | 50.92%-1.93M | 82.93%-7.13M | 86.61%-3.93M | -273.66%-41.77M | -3,360.57%-29.31M | 15.76%-11.18M | 87.93%-847K | 68.64%-13.27M | 63.15%-7.02M | 71.77%-42.32M |
| Net cash before financing | 246.37%157.46M | 268.62%11.75M | 132.42%45.46M | -108.46%-6.97M | -78.40%19.56M | 65.54%82.34M | 100.52%90.57M | -64.49%49.74M | -77.34%45.17M | -15.18%140.09M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 255.99%383.66M | 11.42%451.02M | 34.88%107.77M | 54.32%404.78M | 787.78%79.9M | 28.58%262.3M | --9M | -7.65%204M | ---- | 95.76%220.91M |
| Refund | -59.37%-224.08M | -13.50%-351.78M | -152.99%-140.6M | -43.18%-309.93M | -6,595.78%-55.58M | -12.16%-216.45M | 98.44%-830K | -34.78%-192.98M | 17.41%-53.28M | -27.47%-143.18M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --174.09M |
| Interest paid - financing | 3.31%-12.95M | 12.78%-29.42M | 12.63%-13.39M | 9.28%-33.73M | 42.02%-15.33M | -113.93%-37.18M | -1,220.23%-26.43M | 6.62%-17.38M | -2.09%-2M | 17.35%-18.61M |
| Dividends paid - financing | -2,457.14%-358K | ---27.36M | 86.67%-14K | ---- | -15.38%-105K | 51.43%-8.18M | ---91K | 5.73%-16.83M | ---- | -2.23%-17.86M |
| Other items of the financing business | -807.55%-275.95M | 93.56%-2.07M | 290.00%39M | -6.16%-32.11M | 140.34%10M | 58.68%-30.24M | -16.86%-24.79M | 75.34%-73.18M | 88.59%-21.21M | -61.26%-296.78M |
| Net cash from financing operations | -557.59%-144.49M | 274.59%12.07M | -513.96%-21.97M | 90.93%-6.92M | 107.08%5.31M | 28.93%-76.25M | 10.41%-74.94M | -17.34%-107.29M | 29.05%-83.64M | 62.92%-91.44M |
| Effect of rate | -151.39%-37K | -161.90%-65K | -27.27%72K | -83.41%105K | -78.62%99K | 228.40%633K | 1,643.33%463K | 81.90%-493K | -103.96%-30K | -774.26%-2.72M |
| Net Cash | -44.78%12.97M | 271.60%23.83M | -5.55%23.49M | -328.00%-13.89M | 59.10%24.87M | 110.58%6.09M | 140.62%15.63M | -218.29%-57.55M | -147.26%-38.47M | 159.76%48.65M |
| Begining period cash | 51.08%70.28M | -22.85%46.52M | -22.85%46.52M | 12.55%60.3M | 12.55%60.3M | -52.00%53.57M | -52.00%53.57M | 69.92%111.62M | 69.92%111.62M | -55.22%65.69M |
| Cash at the end | 18.74%83.21M | 51.08%70.28M | -17.81%70.08M | -22.85%46.52M | 22.39%85.26M | 12.55%60.3M | -4.71%69.67M | -52.00%53.57M | -50.55%73.11M | 69.92%111.62M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | PwC accounting firm | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.